跳至主要内容
临床试验/NCT03340649
NCT03340649Unknown不适用

The Predictive Value of Hepatocyte Growth Factor and Soluble Receptor s-Met in Evaluating Sepsis Patient's Disease Severity and Prognosis

Jingyuan,Xu1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2017年11月9日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
90
试验地点
1
主要终点
mortality

研究概览

简要总结

To observe the changes of plasma hepatocyte growth factor and soluble receptor s-Met levels in patients with sepsis, and to explore its clinical significance.

详细描述

90 patients who diagnosed as sepsis were included in this study. Then keep blood samples from these patients in the first day, the third day, detect the hepatocyte growth factor and soluble receptor s-Met level in plasma byenzyme-linked immuno sorbent assay. Record Severity of illness and survival status of every patient within 28 days. Objective to evaluate the correlation between the level of hepatocyte growth factor and soluble receptor s-Met in plasma and the prognosis of the patients.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients admitted to ICU diagnosed of sepsis(sepsis3.0 criteria)
  • Patients signing informed consent

排除标准

  • Age is less than 18 years old or more than 80 years old
  • Pregnant women
  • Patients with tumor、hepatitis、liver cirrhosis、acute myocardial infarction、chronic renal tubular nephritis、interstitial pneumonia、acute pancreatitis、systemic lupus erythenatosus、ulcerative colitis、crohn's disease、HELLP syndrome
  • Prothrombin time is extension in patients with after liver transplantation
  • Patients with chronic renal failure
  • Patients after kidney transplantation

结局指标

主要结局

mortality

时间窗: 28-day

28-day mortality

次要结局

未报告次要终点

研究者

发起方
Jingyuan,Xu
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Jingyuan,Xu

Attending doctor

Southeast University, China

研究点 (1)

Loading locations...

相似试验

The Predictive Value of Hepatocyte Growth Factor and... | 临床试验